fühlst dich wohl in folgendem Tech-Stack: - Java, Spring oder JEE - Cloud bzw. cloud-nahe Technologien wie AWS, MS Azure... ein Dein Fokus in der Entwicklung liegt in Java und den dazugehörigen Spring Frameworks, Core/Web API an den Schnittstellen, GitLab...
Praktische Erfahrung mit Spring Frameworks und Spring Boot; API, Serviceorientierter Architektur oder Microservices; OpenShift...-on experience in building large scale distributed computing solutions Hands-on experience with Spring Frameworks and Spring Boot...
aktuelle Technologien rund um den Java/Spring Boot Techstack und serviceorientierte Strukturen, die über unsere CI/CD Pipelines... in Spring oder Java EE Erfahrung und Führungskompetenz: Mindestens 2 Jahre Berufserfahrung als Senior Java Entwickler (m...
(Java 11, Framework Spring bzw. Spring-Boot) Erfahrung im Bereich der Testautomation (z.B. Gherkin/Cucumber, REST..., Spring-Cloud-Contracts sowie mit Last- und Performancetests mit Gatling oder Apache JMeter exzellente Teamplayer mit guten...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »